nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—NPR1—endothelium—sarcoma	0.0217	0.045	CbGeAlD
Nitroglycerin—GUCY1A2—myometrium—sarcoma	0.0213	0.044	CbGeAlD
Nitroglycerin—GUCY1A3—mammary gland—sarcoma	0.0189	0.039	CbGeAlD
Nitroglycerin—NPR1—mammary gland—sarcoma	0.0175	0.0362	CbGeAlD
Nitroglycerin—ALDH2—mammary gland—sarcoma	0.0159	0.0329	CbGeAlD
Nitroglycerin—GUCY1A3—myometrium—sarcoma	0.0134	0.0277	CbGeAlD
Nitroglycerin—GUCY1B3—myometrium—sarcoma	0.0133	0.0275	CbGeAlD
Nitroglycerin—NPR1—myometrium—sarcoma	0.0124	0.0257	CbGeAlD
Nitroglycerin—GUCY1A3—seminal vesicle—sarcoma	0.0121	0.025	CbGeAlD
Nitroglycerin—GUCY1A2—tendon—sarcoma	0.0121	0.025	CbGeAlD
Nitroglycerin—GUCY1B3—seminal vesicle—sarcoma	0.012	0.0248	CbGeAlD
Nitroglycerin—GUCY1B3—hematopoietic system—sarcoma	0.0114	0.0236	CbGeAlD
Nitroglycerin—ALDH2—myometrium—sarcoma	0.0113	0.0233	CbGeAlD
Nitroglycerin—NPR1—seminal vesicle—sarcoma	0.0112	0.0232	CbGeAlD
Nitroglycerin—NPR1—hematopoietic system—sarcoma	0.0107	0.0221	CbGeAlD
Nitroglycerin—NPR1—connective tissue—sarcoma	0.0103	0.0213	CbGeAlD
Nitroglycerin—ALDH2—seminal vesicle—sarcoma	0.0102	0.0211	CbGeAlD
Nitroglycerin—GUCY1A2—testis—sarcoma	0.01	0.0207	CbGeAlD
Nitroglycerin—ALDH2—hematopoietic system—sarcoma	0.00969	0.02	CbGeAlD
Nitroglycerin—NPR1—smooth muscle tissue—sarcoma	0.0094	0.0194	CbGeAlD
Nitroglycerin—ALDH2—connective tissue—sarcoma	0.00933	0.0193	CbGeAlD
Nitroglycerin—GUCY1A3—cardiac atrium—sarcoma	0.00873	0.0181	CbGeAlD
Nitroglycerin—GUCY1A3—uterus—sarcoma	0.00868	0.018	CbGeAlD
Nitroglycerin—GUCY1B3—cardiac atrium—sarcoma	0.00867	0.0179	CbGeAlD
Nitroglycerin—GUCY1B3—uterus—sarcoma	0.00862	0.0178	CbGeAlD
Nitroglycerin—ALDH2—smooth muscle tissue—sarcoma	0.00853	0.0177	CbGeAlD
Nitroglycerin—ALDH2—skin of body—sarcoma	0.00842	0.0174	CbGeAlD
Nitroglycerin—NPR1—cardiac atrium—sarcoma	0.00811	0.0168	CbGeAlD
Nitroglycerin—NPR1—uterus—sarcoma	0.00806	0.0167	CbGeAlD
Nitroglycerin—GUCY1A3—tendon—sarcoma	0.00761	0.0157	CbGeAlD
Nitroglycerin—GUCY1B3—tendon—sarcoma	0.00755	0.0156	CbGeAlD
Nitroglycerin—GUCY1A3—bone marrow—sarcoma	0.00737	0.0152	CbGeAlD
Nitroglycerin—ALDH2—cardiac atrium—sarcoma	0.00736	0.0152	CbGeAlD
Nitroglycerin—ALDH2—uterus—sarcoma	0.00732	0.0151	CbGeAlD
Nitroglycerin—GUCY1B3—bone marrow—sarcoma	0.00732	0.0151	CbGeAlD
Nitroglycerin—GUCY1A2—lymph node—sarcoma	0.00725	0.015	CbGeAlD
Nitroglycerin—NPR1—tendon—sarcoma	0.00706	0.0146	CbGeAlD
Nitroglycerin—ALDH2—lymphoid tissue—sarcoma	0.00682	0.0141	CbGeAlD
Nitroglycerin—ALDH2—tendon—sarcoma	0.00641	0.0133	CbGeAlD
Nitroglycerin—GUCY1A3—testis—sarcoma	0.0063	0.013	CbGeAlD
Nitroglycerin—GUCY1B3—testis—sarcoma	0.00625	0.0129	CbGeAlD
Nitroglycerin—ALDH2—bone marrow—sarcoma	0.00621	0.0128	CbGeAlD
Nitroglycerin—GUCY1A3—liver—sarcoma	0.00596	0.0123	CbGeAlD
Nitroglycerin—GUCY1B3—liver—sarcoma	0.00591	0.0122	CbGeAlD
Nitroglycerin—NPR1—testis—sarcoma	0.00585	0.0121	CbGeAlD
Nitroglycerin—NPR1—liver—sarcoma	0.00553	0.0114	CbGeAlD
Nitroglycerin—ALDH2—testis—sarcoma	0.00531	0.011	CbGeAlD
Nitroglycerin—ALDH2—liver—sarcoma	0.00502	0.0104	CbGeAlD
Nitroglycerin—GUCY1A3—lymph node—sarcoma	0.00457	0.00945	CbGeAlD
Nitroglycerin—GUCY1B3—lymph node—sarcoma	0.00453	0.00938	CbGeAlD
Nitroglycerin—NPR1—lymph node—sarcoma	0.00424	0.00877	CbGeAlD
Nitroglycerin—ALDH2—lymph node—sarcoma	0.00385	0.00796	CbGeAlD
Nitroglycerin—Pharyngitis—Mitoxantrone—sarcoma	0.00231	0.00447	CcSEcCtD
Nitroglycerin—Vasodilation—Doxorubicin—sarcoma	0.00227	0.0044	CcSEcCtD
Nitroglycerin—Vasodilation procedure—Doxorubicin—sarcoma	0.00227	0.0044	CcSEcCtD
Nitroglycerin—Atrioventricular block—Epirubicin—sarcoma	0.00223	0.00431	CcSEcCtD
Nitroglycerin—Cardiac disorder—Vincristine—sarcoma	0.00222	0.00429	CcSEcCtD
Nitroglycerin—Vision blurred—Thiotepa—sarcoma	0.00221	0.00428	CcSEcCtD
Nitroglycerin—Angiopathy—Vincristine—sarcoma	0.00217	0.00419	CcSEcCtD
Nitroglycerin—Infestation NOS—Etoposide—sarcoma	0.00215	0.00417	CcSEcCtD
Nitroglycerin—Infestation—Etoposide—sarcoma	0.00215	0.00417	CcSEcCtD
Nitroglycerin—Agitation—Thiotepa—sarcoma	0.00215	0.00417	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Vincristine—sarcoma	0.00215	0.00416	CcSEcCtD
Nitroglycerin—Dermatitis contact—Epirubicin—sarcoma	0.00213	0.00413	CcSEcCtD
Nitroglycerin—Stomatitis—Etoposide—sarcoma	0.0021	0.00406	CcSEcCtD
Nitroglycerin—Mental disorder—Vincristine—sarcoma	0.00209	0.00405	CcSEcCtD
Nitroglycerin—Arrhythmia—Mitoxantrone—sarcoma	0.00208	0.00402	CcSEcCtD
Nitroglycerin—Atrioventricular block—Doxorubicin—sarcoma	0.00206	0.00399	CcSEcCtD
Nitroglycerin—Erythema—Mitoxantrone—sarcoma	0.00202	0.00392	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00198	0.00384	CcSEcCtD
Nitroglycerin—Dermatitis contact—Doxorubicin—sarcoma	0.00197	0.00382	CcSEcCtD
Nitroglycerin—Coma—Epirubicin—sarcoma	0.00197	0.00382	CcSEcCtD
Nitroglycerin—Confusional state—Thiotepa—sarcoma	0.00193	0.00373	CcSEcCtD
Nitroglycerin—Agitation—Vincristine—sarcoma	0.00191	0.0037	CcSEcCtD
Nitroglycerin—Vision blurred—Mitoxantrone—sarcoma	0.00191	0.00369	CcSEcCtD
Nitroglycerin—Infection—Thiotepa—sarcoma	0.0019	0.00368	CcSEcCtD
Nitroglycerin—Infection—Dactinomycin—sarcoma	0.00189	0.00365	CcSEcCtD
Nitroglycerin—Nervous system disorder—Thiotepa—sarcoma	0.00188	0.00363	CcSEcCtD
Nitroglycerin—Vertigo—Vincristine—sarcoma	0.00187	0.00361	CcSEcCtD
Nitroglycerin—Tachycardia—Thiotepa—sarcoma	0.00187	0.00361	CcSEcCtD
Nitroglycerin—Skin disorder—Thiotepa—sarcoma	0.00186	0.0036	CcSEcCtD
Nitroglycerin—Coma—Doxorubicin—sarcoma	0.00182	0.00353	CcSEcCtD
Nitroglycerin—Flushing—Etoposide—sarcoma	0.00179	0.00347	CcSEcCtD
Nitroglycerin—Cardiac disorder—Etoposide—sarcoma	0.00179	0.00347	CcSEcCtD
Nitroglycerin—Angiopathy—Etoposide—sarcoma	0.00175	0.0034	CcSEcCtD
Nitroglycerin—Immune system disorder—Etoposide—sarcoma	0.00175	0.00338	CcSEcCtD
Nitroglycerin—Eczema—Epirubicin—sarcoma	0.00174	0.00338	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Etoposide—sarcoma	0.00174	0.00337	CcSEcCtD
Nitroglycerin—Paraesthesia—Thiotepa—sarcoma	0.00172	0.00332	CcSEcCtD
Nitroglycerin—Somnolence—Thiotepa—sarcoma	0.0017	0.00329	CcSEcCtD
Nitroglycerin—Renal failure acute—Epirubicin—sarcoma	0.0017	0.00329	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Vincristine—sarcoma	0.0017	0.00328	CcSEcCtD
Nitroglycerin—Infection—Vincristine—sarcoma	0.00168	0.00326	CcSEcCtD
Nitroglycerin—Hot flush—Epirubicin—sarcoma	0.00167	0.00324	CcSEcCtD
Nitroglycerin—Confusional state—Mitoxantrone—sarcoma	0.00167	0.00322	CcSEcCtD
Nitroglycerin—Nervous system disorder—Vincristine—sarcoma	0.00166	0.00322	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Epirubicin—sarcoma	0.00166	0.00321	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Epirubicin—sarcoma	0.00166	0.00321	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Mitoxantrone—sarcoma	0.00165	0.0032	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Thiotepa—sarcoma	0.00165	0.0032	CcSEcCtD
Nitroglycerin—Infection—Mitoxantrone—sarcoma	0.00164	0.00318	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Vincristine—sarcoma	0.00164	0.00317	CcSEcCtD
Nitroglycerin—Shock—Mitoxantrone—sarcoma	0.00162	0.00315	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Epirubicin—sarcoma	0.00162	0.00313	CcSEcCtD
Nitroglycerin—Eczema—Doxorubicin—sarcoma	0.00161	0.00312	CcSEcCtD
Nitroglycerin—Tachycardia—Mitoxantrone—sarcoma	0.00161	0.00312	CcSEcCtD
Nitroglycerin—Skin disorder—Mitoxantrone—sarcoma	0.0016	0.00311	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Mitoxantrone—sarcoma	0.0016	0.00309	CcSEcCtD
Nitroglycerin—Hypotension—Vincristine—sarcoma	0.00158	0.00307	CcSEcCtD
Nitroglycerin—Feeling abnormal—Thiotepa—sarcoma	0.00158	0.00305	CcSEcCtD
Nitroglycerin—Renal failure acute—Doxorubicin—sarcoma	0.00157	0.00304	CcSEcCtD
Nitroglycerin—Feeling abnormal—Dactinomycin—sarcoma	0.00156	0.00303	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Thiotepa—sarcoma	0.00156	0.00303	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Dactinomycin—sarcoma	0.00155	0.003	CcSEcCtD
Nitroglycerin—Hot flush—Doxorubicin—sarcoma	0.00155	0.003	CcSEcCtD
Nitroglycerin—Hypotension—Mitoxantrone—sarcoma	0.00154	0.00299	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00154	0.00297	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Doxorubicin—sarcoma	0.00154	0.00297	CcSEcCtD
Nitroglycerin—Paraesthesia—Vincristine—sarcoma	0.00152	0.00295	CcSEcCtD
Nitroglycerin—Urticaria—Thiotepa—sarcoma	0.00152	0.00294	CcSEcCtD
Nitroglycerin—Vertigo—Etoposide—sarcoma	0.00151	0.00293	CcSEcCtD
Nitroglycerin—Abdominal pain—Thiotepa—sarcoma	0.00151	0.00293	CcSEcCtD
Nitroglycerin—Body temperature increased—Thiotepa—sarcoma	0.00151	0.00293	CcSEcCtD
Nitroglycerin—Body temperature increased—Dactinomycin—sarcoma	0.0015	0.0029	CcSEcCtD
Nitroglycerin—Abdominal pain—Dactinomycin—sarcoma	0.0015	0.0029	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Doxorubicin—sarcoma	0.0015	0.0029	CcSEcCtD
Nitroglycerin—Paraesthesia—Mitoxantrone—sarcoma	0.00148	0.00287	CcSEcCtD
Nitroglycerin—Loss of consciousness—Etoposide—sarcoma	0.00148	0.00286	CcSEcCtD
Nitroglycerin—Dyspnoea—Mitoxantrone—sarcoma	0.00147	0.00285	CcSEcCtD
Nitroglycerin—Somnolence—Mitoxantrone—sarcoma	0.00147	0.00284	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Vincristine—sarcoma	0.00146	0.00283	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Epirubicin—sarcoma	0.00143	0.00277	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00142	0.00276	CcSEcCtD
Nitroglycerin—Hypersensitivity—Thiotepa—sarcoma	0.00141	0.00273	CcSEcCtD
Nitroglycerin—Hypersensitivity—Dactinomycin—sarcoma	0.0014	0.00271	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Vincristine—sarcoma	0.00139	0.00268	CcSEcCtD
Nitroglycerin—Confusional state—Etoposide—sarcoma	0.00139	0.00268	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Etoposide—sarcoma	0.00137	0.00266	CcSEcCtD
Nitroglycerin—Asthenia—Thiotepa—sarcoma	0.00137	0.00266	CcSEcCtD
Nitroglycerin—Infection—Etoposide—sarcoma	0.00136	0.00264	CcSEcCtD
Nitroglycerin—Asthenia—Dactinomycin—sarcoma	0.00136	0.00264	CcSEcCtD
Nitroglycerin—Feeling abnormal—Mitoxantrone—sarcoma	0.00136	0.00263	CcSEcCtD
Nitroglycerin—Pruritus—Thiotepa—sarcoma	0.00135	0.00262	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00135	0.00261	CcSEcCtD
Nitroglycerin—Tachycardia—Etoposide—sarcoma	0.00134	0.0026	CcSEcCtD
Nitroglycerin—Abdominal pain—Vincristine—sarcoma	0.00134	0.0026	CcSEcCtD
Nitroglycerin—Body temperature increased—Vincristine—sarcoma	0.00134	0.0026	CcSEcCtD
Nitroglycerin—Skin disorder—Etoposide—sarcoma	0.00133	0.00258	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Etoposide—sarcoma	0.00133	0.00257	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Doxorubicin—sarcoma	0.00132	0.00256	CcSEcCtD
Nitroglycerin—Angina pectoris—Epirubicin—sarcoma	0.00132	0.00255	CcSEcCtD
Nitroglycerin—Urticaria—Mitoxantrone—sarcoma	0.00131	0.00254	CcSEcCtD
Nitroglycerin—Body temperature increased—Mitoxantrone—sarcoma	0.00131	0.00253	CcSEcCtD
Nitroglycerin—Abdominal pain—Mitoxantrone—sarcoma	0.00131	0.00253	CcSEcCtD
Nitroglycerin—Hypotension—Etoposide—sarcoma	0.00128	0.00249	CcSEcCtD
Nitroglycerin—Dizziness—Thiotepa—sarcoma	0.00126	0.00245	CcSEcCtD
Nitroglycerin—Hypersensitivity—Vincristine—sarcoma	0.00125	0.00242	CcSEcCtD
Nitroglycerin—Paraesthesia—Etoposide—sarcoma	0.00123	0.00239	CcSEcCtD
Nitroglycerin—Dyspnoea—Etoposide—sarcoma	0.00122	0.00237	CcSEcCtD
Nitroglycerin—Somnolence—Etoposide—sarcoma	0.00122	0.00236	CcSEcCtD
Nitroglycerin—Angina pectoris—Doxorubicin—sarcoma	0.00122	0.00236	CcSEcCtD
Nitroglycerin—Hypersensitivity—Mitoxantrone—sarcoma	0.00122	0.00236	CcSEcCtD
Nitroglycerin—Asthenia—Vincristine—sarcoma	0.00122	0.00236	CcSEcCtD
Nitroglycerin—Vomiting—Thiotepa—sarcoma	0.00122	0.00235	CcSEcCtD
Nitroglycerin—Infestation NOS—Epirubicin—sarcoma	0.00121	0.00234	CcSEcCtD
Nitroglycerin—Infestation—Epirubicin—sarcoma	0.00121	0.00234	CcSEcCtD
Nitroglycerin—Drowsiness—Epirubicin—sarcoma	0.00121	0.00234	CcSEcCtD
Nitroglycerin—Vomiting—Dactinomycin—sarcoma	0.00121	0.00234	CcSEcCtD
Nitroglycerin—Rash—Thiotepa—sarcoma	0.00121	0.00233	CcSEcCtD
Nitroglycerin—Dermatitis—Thiotepa—sarcoma	0.0012	0.00233	CcSEcCtD
Nitroglycerin—Headache—Thiotepa—sarcoma	0.0012	0.00232	CcSEcCtD
Nitroglycerin—Rash—Dactinomycin—sarcoma	0.0012	0.00232	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Etoposide—sarcoma	0.00119	0.0023	CcSEcCtD
Nitroglycerin—Asthenia—Mitoxantrone—sarcoma	0.00118	0.00229	CcSEcCtD
Nitroglycerin—Stomatitis—Epirubicin—sarcoma	0.00118	0.00228	CcSEcCtD
Nitroglycerin—Sweating—Epirubicin—sarcoma	0.00116	0.00224	CcSEcCtD
Nitroglycerin—Nausea—Thiotepa—sarcoma	0.00114	0.0022	CcSEcCtD
Nitroglycerin—Feeling abnormal—Etoposide—sarcoma	0.00113	0.00219	CcSEcCtD
Nitroglycerin—Nausea—Dactinomycin—sarcoma	0.00113	0.00218	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Etoposide—sarcoma	0.00112	0.00217	CcSEcCtD
Nitroglycerin—Dizziness—Vincristine—sarcoma	0.00112	0.00217	CcSEcCtD
Nitroglycerin—Infestation NOS—Doxorubicin—sarcoma	0.00112	0.00216	CcSEcCtD
Nitroglycerin—Infestation—Doxorubicin—sarcoma	0.00112	0.00216	CcSEcCtD
Nitroglycerin—Drowsiness—Doxorubicin—sarcoma	0.00112	0.00216	CcSEcCtD
Nitroglycerin—Bradycardia—Epirubicin—sarcoma	0.0011	0.00214	CcSEcCtD
Nitroglycerin—Urticaria—Etoposide—sarcoma	0.00109	0.00211	CcSEcCtD
Nitroglycerin—Stomatitis—Doxorubicin—sarcoma	0.00109	0.00211	CcSEcCtD
Nitroglycerin—Rhinitis—Epirubicin—sarcoma	0.00109	0.0021	CcSEcCtD
Nitroglycerin—Body temperature increased—Etoposide—sarcoma	0.00109	0.0021	CcSEcCtD
Nitroglycerin—Abdominal pain—Etoposide—sarcoma	0.00109	0.0021	CcSEcCtD
Nitroglycerin—Vomiting—Vincristine—sarcoma	0.00108	0.00209	CcSEcCtD
Nitroglycerin—Pharyngitis—Epirubicin—sarcoma	0.00108	0.00208	CcSEcCtD
Nitroglycerin—Sweating—Doxorubicin—sarcoma	0.00107	0.00207	CcSEcCtD
Nitroglycerin—Rash—Vincristine—sarcoma	0.00107	0.00207	CcSEcCtD
Nitroglycerin—Dermatitis—Vincristine—sarcoma	0.00107	0.00207	CcSEcCtD
Nitroglycerin—Oedema peripheral—Epirubicin—sarcoma	0.00107	0.00207	CcSEcCtD
Nitroglycerin—Headache—Vincristine—sarcoma	0.00106	0.00206	CcSEcCtD
Nitroglycerin—Vomiting—Mitoxantrone—sarcoma	0.00105	0.00203	CcSEcCtD
Nitroglycerin—Visual impairment—Epirubicin—sarcoma	0.00104	0.00202	CcSEcCtD
Nitroglycerin—Rash—Mitoxantrone—sarcoma	0.00104	0.00202	CcSEcCtD
Nitroglycerin—Dermatitis—Mitoxantrone—sarcoma	0.00104	0.00201	CcSEcCtD
Nitroglycerin—Headache—Mitoxantrone—sarcoma	0.00103	0.002	CcSEcCtD
Nitroglycerin—Bradycardia—Doxorubicin—sarcoma	0.00102	0.00198	CcSEcCtD
Nitroglycerin—Hypersensitivity—Etoposide—sarcoma	0.00101	0.00196	CcSEcCtD
Nitroglycerin—Nausea—Vincristine—sarcoma	0.00101	0.00195	CcSEcCtD
Nitroglycerin—Flushing—Epirubicin—sarcoma	0.00101	0.00195	CcSEcCtD
Nitroglycerin—Cardiac disorder—Epirubicin—sarcoma	0.00101	0.00195	CcSEcCtD
Nitroglycerin—Rhinitis—Doxorubicin—sarcoma	0.00101	0.00195	CcSEcCtD
Nitroglycerin—Pharyngitis—Doxorubicin—sarcoma	0.000995	0.00193	CcSEcCtD
Nitroglycerin—Oedema peripheral—Doxorubicin—sarcoma	0.000988	0.00191	CcSEcCtD
Nitroglycerin—Asthenia—Etoposide—sarcoma	0.000986	0.00191	CcSEcCtD
Nitroglycerin—Angiopathy—Epirubicin—sarcoma	0.000983	0.0019	CcSEcCtD
Nitroglycerin—Nausea—Mitoxantrone—sarcoma	0.000981	0.0019	CcSEcCtD
Nitroglycerin—Immune system disorder—Epirubicin—sarcoma	0.000979	0.0019	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Epirubicin—sarcoma	0.000977	0.00189	CcSEcCtD
Nitroglycerin—Pruritus—Etoposide—sarcoma	0.000972	0.00188	CcSEcCtD
Nitroglycerin—Arrhythmia—Epirubicin—sarcoma	0.000968	0.00187	CcSEcCtD
Nitroglycerin—Visual impairment—Doxorubicin—sarcoma	0.000966	0.00187	CcSEcCtD
Nitroglycerin—Mental disorder—Epirubicin—sarcoma	0.00095	0.00184	CcSEcCtD
Nitroglycerin—Erythema—Epirubicin—sarcoma	0.000943	0.00183	CcSEcCtD
Nitroglycerin—Cardiac disorder—Doxorubicin—sarcoma	0.000931	0.0018	CcSEcCtD
Nitroglycerin—Flushing—Doxorubicin—sarcoma	0.000931	0.0018	CcSEcCtD
Nitroglycerin—Angiopathy—Doxorubicin—sarcoma	0.00091	0.00176	CcSEcCtD
Nitroglycerin—Dizziness—Etoposide—sarcoma	0.000908	0.00176	CcSEcCtD
Nitroglycerin—Immune system disorder—Doxorubicin—sarcoma	0.000906	0.00175	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Doxorubicin—sarcoma	0.000904	0.00175	CcSEcCtD
Nitroglycerin—Arrhythmia—Doxorubicin—sarcoma	0.000896	0.00173	CcSEcCtD
Nitroglycerin—Vision blurred—Epirubicin—sarcoma	0.000889	0.00172	CcSEcCtD
Nitroglycerin—Mental disorder—Doxorubicin—sarcoma	0.000879	0.0017	CcSEcCtD
Nitroglycerin—Vomiting—Etoposide—sarcoma	0.000873	0.00169	CcSEcCtD
Nitroglycerin—Erythema—Doxorubicin—sarcoma	0.000873	0.00169	CcSEcCtD
Nitroglycerin—Agitation—Epirubicin—sarcoma	0.000867	0.00168	CcSEcCtD
Nitroglycerin—Rash—Etoposide—sarcoma	0.000866	0.00168	CcSEcCtD
Nitroglycerin—Dermatitis—Etoposide—sarcoma	0.000865	0.00168	CcSEcCtD
Nitroglycerin—Headache—Etoposide—sarcoma	0.000861	0.00167	CcSEcCtD
Nitroglycerin—Vertigo—Epirubicin—sarcoma	0.000848	0.00164	CcSEcCtD
Nitroglycerin—Syncope—Epirubicin—sarcoma	0.000846	0.00164	CcSEcCtD
Nitroglycerin—Palpitations—Epirubicin—sarcoma	0.000834	0.00161	CcSEcCtD
Nitroglycerin—Loss of consciousness—Epirubicin—sarcoma	0.000829	0.00161	CcSEcCtD
Nitroglycerin—Vision blurred—Doxorubicin—sarcoma	0.000823	0.00159	CcSEcCtD
Nitroglycerin—Nausea—Etoposide—sarcoma	0.000816	0.00158	CcSEcCtD
Nitroglycerin—Agitation—Doxorubicin—sarcoma	0.000802	0.00155	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000798	0.00154	CcSEcCtD
Nitroglycerin—Vertigo—Doxorubicin—sarcoma	0.000784	0.00152	CcSEcCtD
Nitroglycerin—Syncope—Doxorubicin—sarcoma	0.000783	0.00152	CcSEcCtD
Nitroglycerin—Confusional state—Epirubicin—sarcoma	0.000776	0.0015	CcSEcCtD
Nitroglycerin—Palpitations—Doxorubicin—sarcoma	0.000771	0.00149	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Epirubicin—sarcoma	0.00077	0.00149	CcSEcCtD
Nitroglycerin—Loss of consciousness—Doxorubicin—sarcoma	0.000767	0.00149	CcSEcCtD
Nitroglycerin—Infection—Epirubicin—sarcoma	0.000765	0.00148	CcSEcCtD
Nitroglycerin—Shock—Epirubicin—sarcoma	0.000758	0.00147	CcSEcCtD
Nitroglycerin—Nervous system disorder—Epirubicin—sarcoma	0.000755	0.00146	CcSEcCtD
Nitroglycerin—Tachycardia—Epirubicin—sarcoma	0.000752	0.00146	CcSEcCtD
Nitroglycerin—Skin disorder—Epirubicin—sarcoma	0.000748	0.00145	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Epirubicin—sarcoma	0.000744	0.00144	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000738	0.00143	CcSEcCtD
Nitroglycerin—Hypotension—Epirubicin—sarcoma	0.00072	0.00139	CcSEcCtD
Nitroglycerin—Confusional state—Doxorubicin—sarcoma	0.000718	0.00139	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Doxorubicin—sarcoma	0.000712	0.00138	CcSEcCtD
Nitroglycerin—Infection—Doxorubicin—sarcoma	0.000708	0.00137	CcSEcCtD
Nitroglycerin—Shock—Doxorubicin—sarcoma	0.000701	0.00136	CcSEcCtD
Nitroglycerin—Nervous system disorder—Doxorubicin—sarcoma	0.000699	0.00135	CcSEcCtD
Nitroglycerin—Tachycardia—Doxorubicin—sarcoma	0.000695	0.00135	CcSEcCtD
Nitroglycerin—Skin disorder—Doxorubicin—sarcoma	0.000692	0.00134	CcSEcCtD
Nitroglycerin—Paraesthesia—Epirubicin—sarcoma	0.000691	0.00134	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Doxorubicin—sarcoma	0.000689	0.00133	CcSEcCtD
Nitroglycerin—Dyspnoea—Epirubicin—sarcoma	0.000686	0.00133	CcSEcCtD
Nitroglycerin—Somnolence—Epirubicin—sarcoma	0.000685	0.00133	CcSEcCtD
Nitroglycerin—Hypotension—Doxorubicin—sarcoma	0.000666	0.00129	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000665	0.00129	CcSEcCtD
Nitroglycerin—Paraesthesia—Doxorubicin—sarcoma	0.00064	0.00124	CcSEcCtD
Nitroglycerin—Dyspnoea—Doxorubicin—sarcoma	0.000635	0.00123	CcSEcCtD
Nitroglycerin—Feeling abnormal—Epirubicin—sarcoma	0.000635	0.00123	CcSEcCtD
Nitroglycerin—Somnolence—Doxorubicin—sarcoma	0.000633	0.00123	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Epirubicin—sarcoma	0.00063	0.00122	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000615	0.00119	CcSEcCtD
Nitroglycerin—Urticaria—Epirubicin—sarcoma	0.000612	0.00118	CcSEcCtD
Nitroglycerin—Abdominal pain—Epirubicin—sarcoma	0.000609	0.00118	CcSEcCtD
Nitroglycerin—Body temperature increased—Epirubicin—sarcoma	0.000609	0.00118	CcSEcCtD
Nitroglycerin—Feeling abnormal—Doxorubicin—sarcoma	0.000587	0.00114	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000583	0.00113	CcSEcCtD
Nitroglycerin—Hypersensitivity—Epirubicin—sarcoma	0.000567	0.0011	CcSEcCtD
Nitroglycerin—Urticaria—Doxorubicin—sarcoma	0.000566	0.0011	CcSEcCtD
Nitroglycerin—Body temperature increased—Doxorubicin—sarcoma	0.000563	0.00109	CcSEcCtD
Nitroglycerin—Abdominal pain—Doxorubicin—sarcoma	0.000563	0.00109	CcSEcCtD
Nitroglycerin—Asthenia—Epirubicin—sarcoma	0.000552	0.00107	CcSEcCtD
Nitroglycerin—Pruritus—Epirubicin—sarcoma	0.000545	0.00105	CcSEcCtD
Nitroglycerin—Hypersensitivity—Doxorubicin—sarcoma	0.000525	0.00102	CcSEcCtD
Nitroglycerin—Asthenia—Doxorubicin—sarcoma	0.000511	0.00099	CcSEcCtD
Nitroglycerin—Dizziness—Epirubicin—sarcoma	0.000509	0.000986	CcSEcCtD
Nitroglycerin—Pruritus—Doxorubicin—sarcoma	0.000504	0.000976	CcSEcCtD
Nitroglycerin—Vomiting—Epirubicin—sarcoma	0.00049	0.000948	CcSEcCtD
Nitroglycerin—Rash—Epirubicin—sarcoma	0.000486	0.00094	CcSEcCtD
Nitroglycerin—Dermatitis—Epirubicin—sarcoma	0.000485	0.000939	CcSEcCtD
Nitroglycerin—Headache—Epirubicin—sarcoma	0.000482	0.000934	CcSEcCtD
Nitroglycerin—Dizziness—Doxorubicin—sarcoma	0.000471	0.000912	CcSEcCtD
Nitroglycerin—Nausea—Epirubicin—sarcoma	0.000457	0.000886	CcSEcCtD
Nitroglycerin—Vomiting—Doxorubicin—sarcoma	0.000453	0.000877	CcSEcCtD
Nitroglycerin—Rash—Doxorubicin—sarcoma	0.000449	0.00087	CcSEcCtD
Nitroglycerin—Dermatitis—Doxorubicin—sarcoma	0.000449	0.000869	CcSEcCtD
Nitroglycerin—Headache—Doxorubicin—sarcoma	0.000446	0.000864	CcSEcCtD
Nitroglycerin—Nausea—Doxorubicin—sarcoma	0.000423	0.000819	CcSEcCtD
